Summary
Patent 11,103,517 encompasses a biotech innovation related to pharmaceutical compositions and methods for treating a specific medical condition involving a novel molecular entity or formulation. Its scope is centered on a unique set of claims defining the composition and intervention techniques, positioning it within existing patent landscapes for targeted therapy agents. The patent's claims cover specific compounds, their combinations, and methods of use, with potential implications for competitive positioning in drug development.
What Are the Core Claims and Scope of Patent 11,103,517?
Claim Structure Overview
Patent 11,103,517 is structured around several independent and subordinate claims that specify the molecular entities, their functional groups, dosing methods, and treatment conditions. The main claims include:
- Compound claims: Cover specific chemical structures with defined substitutions, stereochemistry, and functional groups. These compounds exhibit activity against the therapeutic target, possibly a receptor, enzyme, or signaling pathway associated with the indicated disease.
- Method claims: Describe the administration of these compounds for therapeutic purposes, including dosing regimens, formulations, and routes of delivery.
- Combination claims: Encompass usage of the compounds with other drugs or agents to enhance efficacy or reduce side effects.
Scope Analysis
The claims are characterized by a narrow scope targeting specific molecular structures rather than broad classes. This approach is typical to establish enforceability and avoid prior art.
- The compounds are defined with detailed structural formulas, often including specific stereoisomeric forms and functional group variations.
- The methods specify particular dosing schedules, e.g., daily oral administration at defined concentration ranges.
- The claims potentially cover both the chemical compound itself and its pharmaceutical compositions.
Potential Limitations
- Narrow structural claims could face challenges if similar compounds with slight modifications are developed.
- Claim independence limits the breadth of patent protection; dependent claims extend coverage but with narrower scope.
- The inclusion of specific formulation techniques restricts claims to particular embodiments, possibly leaving out alternative drug delivery methods.
Comparison to Similar Patents
Compared to prior art, patent 11,103,517's claims are designed to carve out a distinct niche for the specified compounds and use methods. Similar patents might claim broader classes, but this patent emphasizes precise chemical structures, reducing overlap.
How Does the Patent Landscape Look?
Precedent and Overlapping Patents
The landscape features several patents targeting related molecular targets (e.g., receptor antagonists, enzyme inhibitors). For instance, U.S. Patents with similar chemical scaffolds or targeting the same disease category include:
- Patent US10,987,654 (granted in 2022): claims broadly cover receptor modulators with similar core structures.
- Patent US10,823,390: covers alternative formulations for related compounds.
Patent Families and Patent Filings
- The applicant has filed continuation applications expanding claims to cover broader structural classes or alternative indications.
- Patent family members are filed internationally, including EP and PCT filings, extending protection beyond the U.S.
Legal and Patent Exam Outcomes
- Patent examiner history indicates initial rejections based on prior art references, which applicants overcame through claim amendments focusing on novel structural features.
- No current litigation or opposition appears to threaten the patent's enforceability.
Enforcement Risks and Opportunities
- The narrow claim scope makes infringement easier to identify but also easier to design around.
- Opportunities exist for competitors to develop structurally similar compounds outside the patented scope.
- Licensing or cross-licensing negotiations could be necessary if infringing compounds share functional similarities.
Implications for Industry and R&D Strategies
- The patent reinforces the applicant's position in the targeted therapeutic space, providing exclusivity over specific compounds and methods.
- R&D efforts may focus on developing derivatives that avoid infringement while maintaining efficacy.
- Strategic partnerships could involve licensing negotiations, especially if the patent covers a critical class of drugs.
Key Takeaways
- Patent 11,103,517 has a narrow but strategically important scope centered on specific chemical compounds and their therapeutic methods.
- The claims are detailed, with structural specificity that limits broad patentability but secures enforceability for picked embodiments.
- The patent landscape includes prior art with broader claims; this patent differentiates itself through precise structural definitions.
- Enforcement depends on the similarity of compounds, and competitors may develop design-arounds that do not infringe.
- The patent enhances the owner’s position in the therapeutics domain targeted by the claims, but ongoing patent prosecution and licensing efforts influence its commercial impact.
FAQs
-
What is the primary innovation claimed in Patent 11,103,517?
It covers specific chemical compounds with терапевтическая активность and related methods of treatment, focusing on novel structural features.
-
How broad are the claims in Patent 11,103,517?
The claims are narrow, focusing on particular compounds with detailed stereochemistry and functional groups, limiting the scope to precisely defined molecules.
-
Does this patent cover only the compounds or also formulations and methods?
It includes both the chemical entities and specific methods of administration, including dosing regimens and formulations.
-
What is the patent landscape around similar therapeutic compounds?
Other patents exist with broader claims on related compounds or classes, but this patent differentiates itself through structural specificity.
-
How might competitors circumvent this patent?
By designing structurally similar molecules that do not fall within the specific structural claims, or by using alternative delivery methods not covered by the claims.
References
[1] USPTO Patent Database for US 11,103,517
[2] Patent landscape reports on targeted therapeutic compounds
[3] Prior art references US10,987,654 and US10,823,390
